Abstract
DESPITE many investigations of royal jelly1, its chemistry and pharmacological activity have not been completely established. As part of a long-term study on the chemistry and biological activity of royal jelly2 we have recently investigated its possible anti-tumour properties. In this communication we wish to report that admixture of royal jelly with tumour cells before inoculation completely suppresses the development of a transplantable mouse leukæmia and the formation of ascitic tumours in mice. Fractionation studies have established that this anti-tumour activity resides in the main fatty acid of the royal jelly—10-hydroxydecenoic acid.
Your institute does not have access to this article
Relevant articles
Open Access articles citing this article.
-
Molecular insights into the enhanced performance of royal jelly secretion by a stock of honeybee (Apis mellifera ligustica) selected for increasing royal jelly production
Apidologie Open Access 17 June 2019
-
10-hydroxy-2-decenoic acid of royal jelly exhibits bactericide and anti-inflammatory activity in human colon cancer cells
BMC Complementary and Alternative Medicine Open Access 03 July 2018
Access options
Subscribe to Journal
Get full journal access for 1 year
$199.00
only $3.90 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.
References
Johansson, S. K., Bee World, 36, 3, 21 (1955).
Townsend, G. F., and Lucas, C. C., Biochem. J., 34, 1155 (1940).
Burchenal, J. H., Lester, R. A., Riley, J. B., and Rhoads, C. P., Cancer, 1, 399 (1948).
Gey, G. O., and Gey, M. K., Amer. J. Cancer, 27, 45 (1936).
Weisberger, A. S., and Pensky, J., Science, 126, 112 (1957).
Morgan, J. F., Guerin, L. F., and Morton, H. J., Cancer Res., 16, 907 (1956).
Hanks, J. H., and Wallace, R. E., Proc. Soc. Exp. Biol. Med., 71, 196 (1949).
Willson, R. B., Amer. Bee J., 97, 356, 396 (1957).
Butenandt, A., Nova Acta Leopoldina, N. F., 17, 445 (1955).
Medes, G., and Weinhouse, S., Cancer Res., 18, 352 (1958).
Burchenal, J. H., Cremer, M. A., Williams, B. S., and Armstrong, R. A., Cancer Res., 11, 700 (1951).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
TOWNSEND, G., MORGAN, J. & HAZLETT, B. Activity of 10-Hydroxydecenoic Acid from Royal Jelly against Experimental Leukæmia and Ascitic Tumours. Nature 183, 1270–1271 (1959). https://doi.org/10.1038/1831270a0
Issue Date:
DOI: https://doi.org/10.1038/1831270a0
Further reading
-
Molecular insights into the enhanced performance of royal jelly secretion by a stock of honeybee (Apis mellifera ligustica) selected for increasing royal jelly production
Apidologie (2019)
-
10-hydroxy-2-decenoic acid of royal jelly exhibits bactericide and anti-inflammatory activity in human colon cancer cells
BMC Complementary and Alternative Medicine (2018)
-
Effects of royal jelly supplementation on glycemic control and oxidative stress factors in type 2 diabetic female: A randomized clinical trial
Chinese Journal of Integrative Medicine (2014)
-
Comparison of the Lipid Content, Fatty Acid Profile and Sterol Composition in Local Italian and Commercial Royal Jelly Samples
Journal of the American Oil Chemists' Society (2014)
-
Using proteomics platform to develop a potential immunoassay method of royal jelly freshness
European Food Research and Technology (2013)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
